Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Biocytogen Re-organizes into Preclinical Service and Drug Discovery Divisions

publication date: Aug 31, 2023

Beijing Biocytogen Pharma restructured its various operations into two major business divisions: “BioMice™” for the company’s wide range of preclinical services, and an unnamed division specializing in discovery of novel antibody drugs for out-licensings and partnerships. The company said it would release more information about the drug discovery division soon, which could mean a spin-out, eventual IPO, or maybe just a division name. Using its proprietary mice platforms, Biocytogen discovers fully human monoclonal and bispecific/multispecific antibodies and nanobody drugs. Biocytogen has signed 50 therapeutic antibody co-development/out-licensing/transfer agreements and 42 RenMiceTM licensing projects worldwide. More details....

Stock Symbol: (HK: 02315)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital